Market Challenges And Opportunities
Global Shigella Test Kit Market Drivers:
- Increasing incidence of shigella infections: Shigella infections are a significant public health problem globally, which a high incidence in the developing countries. The increasing incidence of shigella infections is driving the demand for accurate and rapid diagnostic tests, thus boosting the growth of the shigella test kit market. For instance, in August, 2022, according to the data published by the National Center for Biotechnology Information (NCBI), the incidence of shigellosis is reported to be 188 Mn cases per year with approximately 1 Mn deaths annually.
- Rising demand for accurate and rapid diagnostic tests: The need for accurate and rapid diagnostic tests for shigella infections is increasing due to the significant morbidity and mortality which are associated with the disease. Rising demand for such tests is driving the global shigella test kit market growth.
- Increasing healthcare expenditure: The increasing healthcare expenditure globally is driving the adoption of advanced diagnostic tests for shigella infections. This is because, governments and healthcare providers are investing more in the development and adoption of such tests, thus leading to the growth of the Shigella test kit market. For instance, in February 2019, according to the data published by the World Health Organization, there is swift upward trajectory of global health expenditure which is particularly noticeable in low and middle income countries where healthcare expenditures is growing on average 6% annually, as compared with 4% in high income countries.
- Growing awareness about shigella infections: The growing awareness about shigella infections among healthcare providers and the general public is driving the demand for accurate and rapid diagnostic tests. This is further boosting the growth of the shigella test kit market.
Global Shigella Test Kit Market Opportunities:
- Expansion of the market in developing countries: The high incidence of shigella infections in developing countries presents an opportunity for market players to expand their business in these regions by providing affordable and accessible diagnostic tests. For instance, in 2020, according to the data published by the European Center for Disease Prevention and Contro, 29 countries reported 1930 cases of shigellosis of which 1, 806 were confirmed cases.
- Introduction of multiplex test kits: The development of multiplex test kits that can simultaneously detect multiple pathogens, including shigella, presents an opportunity for market players to cater to the growing demand for comprehensive diagnostic tests.
- Strategic partnerships and collaborations: Partnerships and collaborations between market players and healthcare providers can help in the development and adoption of advanced diagnostic technologies for shigella infections. Such partnerships can also help in the expansion of the market.
- Government initiatives: Government initiatives which are aimed at increasing awareness about Shigella infections and the development and adoption of diagnostic tests presents an opportunity for market players to partner with governments and expand their business.
Global Shigella Test Kit Market Restraints:
- Limited availability of advanced healthcare infrastructure: The limited availability of advanced healthcare infrastructure in developing countries can hinder the global shigella test kit market growth by limiting the adoption of diagnostic tests for shigella infections.
- Increase in drug resistance: Increasing shigella drug resistance is expected to hinder the market growth over the forecast period. For instance, in February 2023, according to the data published by the Center for Disease Control and Prevention (CDC), there is an increase in extensively drug resistance shigella infections in the U.S.
- Lack of awareness about shigella infections: The lack of awareness about shigella infections among healthcare providers and the general public can hinder the global shigella test kit market growth by limiting the demand for diagnostic tests.
- Stringent regulatory requirements: The regulatory requirements for the approval of diagnostic tests can be stringent and time-consuming, which can hinder the global shigella test kit market growth by delaying the introduction of new products.